This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
By Frederick Fromm, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group While caution in some areas of the commodities space may be prudent, there...
ImmunoGen (NASDAQ:IMGN) is a large biopharmaceutical company (market cap of $4.8 billion) that uses antibody-drug conjugate (‘ADC’) technology to develop novel therapeutics against cancer....
Repligen (NASDAQ:RGEN) offers a comprehensive suite of products, including filtration, chromatography, process analytics, and proteins, catering to both upstream and downstream processes in the...
Living with memory loss and other cognitive limitations is hard. But when you can’t remember or can’t process information well enough to make important...
Investment thesis Synaptics (NASDAQ:SYNA) is experiencing severe headwinds due to the challenging environment with weak end markets’ spending. On the other hand, secular trends...